21 years treating AML
Dr. Pullarkat’s research interests include treatment of acute leukemia, stem cell transplantation, bone marrow failure and autoimmune hematologic disorders. His basic research focusses on new drug development for acute leukemia. Dr. Pullarkat has authored over 125 scientific articles in various peer reviewed journals and edited books on acute leukemia. He serves as principal investigator for multiple clinical trials at City of Hope.
Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.
Terms of Use and Privacy Policy Newsroom About Donations Find an AML Specialist Newsletter Learn Connect
Copyright © 2022 HealthTree Foundation. All Rights Reserved.
The HealthTree Foundation / HealthTree for AML is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811